[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), AND PROTEIN SEQUENCE OF N-TERMINUS.
TISSUE=Foreskin fibroblast;
DOI=10.1093/emboj/16.17.5386; PubMed=9311998 [NCBI, ExPASy, EBI, Israel, Japan]
Walczak H.,
Degli-Esposti M.A.,
Johnson R.S.,
Smolak P.J.,
Waugh J.Y.,
Boiani N.,
Timour M.S.,
Gerhart M.J.,
Schooley K.A.,
Smith C.A.,
Goodwin R.G.,
Rauch C.T.;
"TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.";
EMBO J. 16:5386-5397(1997).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT), ALTERNATIVE SPLICING, AND VARIANTS LEU-32 AND VAL-67.
DOI=10.1016/S0960-9822(06)00297-1; PubMed=9285725 [NCBI, ExPASy, EBI, Israel, Japan]
Screaton G.R.,
Mongkolsapaya J.,
Xu X.-N.,
Cowper A.E.,
McMichael A.J.,
Bell J.I.;
"TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL.";
Curr. Biol. 7:693-696(1997).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), CHARACTERIZATION, AND VARIANTS LEU-32 AND VAL-67.
TISSUE=Liver, and Spleen;
DOI=10.1016/S0014-5793(97)01231-3; PubMed=9373179 [NCBI, ExPASy, EBI, Israel, Japan]
Schneider P.,
Bodmer J.-L.,
Thome M.,
Hofmann K.,
Holler N.,
Tschopp J.;
"Characterization of two receptors for TRAIL.";
FEBS Lett. 416:329-334(1997).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
TISSUE=Ovary;
DOI=10.1038/ng1097-141; PubMed=9326928 [NCBI, ExPASy, EBI, Israel, Japan]
Wu G.S.,
Burns T.F.,
McDonald E.R. III,
Jiang W.,
Meng R.,
Krantz I.D.,
Kao G.,
Gan D.D.,
Zhou J.Y.,
Muschel R.,
Hamilton S.R.,
Spinner N.B.,
Markowitz S.,
Wu G.,
el-Deiry W.S.;
"KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene.";
Nat. Genet. 17:141-143(1997).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
DOI=10.1126/science.277.5327.815; PubMed=9242610 [NCBI, ExPASy, EBI, Israel, Japan]
Pan G.,
Ni J.,
Wei Y.-F.,
Yu G.-L.,
Gentz R.,
Dixit V.M.;
"An antagonist decoy receptor and a death domain-containing receptor for TRAIL.";
Science 277:815-818(1997).
|
[6]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), AND VARIANTS LEU-32 AND VAL-67.
DOI=10.1074/jbc.272.41.25417; PubMed=9325248 [NCBI, ExPASy, EBI, Israel, Japan]
MacFarlane M.,
Ahmad M.,
Srinivasula S.M.,
Fernandes-Alnemri T.,
Cohen G.M.,
Alnemri E.S.;
"Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL.";
J. Biol. Chem. 272:25417-25420(1997).
|
[7]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), AND VARIANTS LEU-32 AND VAL-67.
DOI=10.1016/S1074-7613(00)80400-8; PubMed=9430227 [NCBI, ExPASy, EBI, Israel, Japan]
Chaudhary P.M.,
Eby M.,
Jasmin A.,
Bookwalter A.,
Murray J.,
Hood L.;
"Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway.";
Immunity 7:821-830(1997).
|
[8]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), AND VARIANT LEU-32.
DOI=10.1126/science.277.5327.818; PubMed=9242611 [NCBI, ExPASy, EBI, Israel, Japan]
Sheridan J.P.,
Marsters S.A.,
Pitti R.M.,
Gurney A.,
Skubatch M.,
Baldwin D.T.,
Ramakrishnan L.,
Gray C.L.,
Baker K.,
Wood W.I.,
Goddard A.D.,
Godowski P.J.,
Ashkenazi A.;
"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.";
Science 277:818-821(1997).
|
[9]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND VARIANTS LEU-32 AND VAL-67.
DOI=10.1016/S0304-3835(98)00230-4; PubMed=10072170 [NCBI, ExPASy, EBI, Israel, Japan]
Arai T.,
Akiyama Y.,
Okabe S.,
Saito K.,
Iwai T.,
Yuasa Y.;
"Genomic organization and mutation analyses of the DR5/TRAIL receptor 2 gene in colorectal carcinomas.";
Cancer Lett. 133:197-204(1998).
|
[10]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
Cao X.,
Zhang W.,
Wan T.;
Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
|
[11]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), AND VARIANTS LEU-32 AND VAL-67.
Farrah T.,
Vu T.,
Gilbert T.,
Gross J.,
O'Hara P.;
"Homo sapiens homolog of tumor necrosis factor receptor.";
Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
|
[12]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT), AND VARIANT LEU-32.
DOI=10.1101/gr.1293003; PubMed=12975309 [NCBI, ExPASy, EBI, Israel, Japan]
Clark H.F.,
Gurney A.L.,
Abaya E.,
Baker K.,
Baldwin D.T.,
Brush J.,
Chen J.,
Chow B.,
Chui C.,
Crowley C.,
Currell B.,
Deuel B.,
Dowd P.,
Eaton D.,
Foster J.S.,
Grimaldi C.,
Gu Q.,
Hass P.E.,
Heldens S., ![]()
Huang A.,
Kim H.S.,
Klimowski L.,
Jin Y.,
Johnson S.,
Lee J.,
Lewis L.,
Liao D.,
Mark M.R.,
Robbie E.,
Sanchez C.,
Schoenfeld J.,
Seshagiri S.,
Simmons L.,
Singh J.,
Smith V.,
Stinson J.,
Vagts A.,
Vandlen R.L.,
Watanabe C.,
Wieand D.,
Woods K.,
Xie M.-H.,
Yansura D.G.,
Yi S.,
Yu G.,
Yuan J.,
Zhang M.,
Zhang Z.,
Goddard A.D.,
Wood W.I.,
Godowski P.J.,
Gray A.M.;
"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.";
Genome Res. 13:2265-2270(2003).
|
[13]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG), AND VARIANT LEU-32.
TISSUE=Cervix;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[14]
|
SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
DOI=10.1186/gb-2004-5-2-r8; PubMed=14759258 [NCBI, ExPASy, EBI, Israel, Japan]
Hillman R.T.,
Green R.E.,
Brenner S.E.;
"An unappreciated role for RNA surveillance.";
Genome Biol. 5:RESEARCH008.1-RESEARCH008.16(2004).
|
[15]
|
X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 54-183.
DOI=10.1016/S1097-2765(00)80207-5; PubMed=10549288 [NCBI, ExPASy, EBI, Israel, Japan]
Hymowitz S.G.,
Christinger H.W.,
Fuh G.,
Ultsch M.,
O'Connell M.,
Kelley R.F.,
Ashkenazi A.,
de Vos A.M.;
"Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.";
Mol. Cell 4:563-571(1999).
|
[16]
|
X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 69-184.
DOI=10.1038/14935; PubMed=10542098 [NCBI, ExPASy, EBI, Israel, Japan]
Mongkolsapaya J.,
Grimes J.M.,
Chen N.,
Xu X.-N.,
Stuart D.I.,
Jones E.Y.,
Screaton G.R.;
"Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.";
Nat. Struct. Biol. 6:1048-1053(1999).
|
|
ExPASy Home page
YPRC Korea
